
COPD Inhaler | ANORO ELLIPTA (umeclidinium and vilanterol …
Learn more about ANORO ELLIPTA, a once-daily prescription medication to treat chronic obstructive pulmonary disease. See Full Safety & Prescribing Information.
Risks & Side Effects | ANORO ELLIPTA (umeclidinium and vilanterol ...
Common side effects of ANORO ELLIPTA include: sore throat; sinus infection; lower respiratory infection; common cold symptoms; constipation; diarrhea; pain in your arms or legs; muscle spasms; neck pain; chest pain.
Watch: How to use your ANORO ELLIPTA inhaler
Follow instructions for using your ANORO ELLIPTA inhaler correctly. See Full Safety & Prescribing Information.
About ANORO | ANORO ELLIPTA (umeclidinium and vilanterol …
Once-daily ANORO is a prescription medicine used long term to treat chronic obstructive pulmonary disease (COPD), including chronic bronchitis, emphysema, or both, for better breathing and to reduce the number of flare-ups.
Your ANORO ELLIPTA inhaler Please see full Prescribing information, including Patient Information, for ANORO available at ANORO.com
ANORO Results | ANORO ELLIPTA (umeclidinium and vilanterol …
Find clinical study results for ANORO ELLIPTA, studied in patients with moderate to severe COPD. See Full Safety & Prescribing Information.
WHAT IS COPD? - ANORO
Once-daily ANORO is a prescription medicine used long term to treat chronic obstructive pulmonary disease (COPD), including chronic bronchitis, emphysema, or both, for better breathing and to reduce the number of flare-ups.
Sharon's Story: - ANORO
Hear Sharon's story about going to the doctor after feeling out of breath too many times and her experience with ANORO ELLIPTA as a COPD maintenance treatment.
TALK TO YOUR DOCTOR - ANORO
Speak with your doctor about your COPD symptoms and whether ANORO ELLIPTA is right for you. See Full Safety & Prescribing Information.
COPD Patient Stories | ANORO ELLIPTA (umeclidinium and …
Hear from real COPD patients about their experiences before and after taking ANORO ELLIPTA. See Full Safety & Prescribing Information.